Literature DB >> 1613620

"Optimal" cost-effectiveness analyses?

S D Nightingale.   

Abstract

Mesh:

Year:  1992        PMID: 1613620     DOI: 10.1007/bf02598099

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Therapeutic decision making: a cost-benefit analysis.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

Review 2.  Decision analysis: a progress report.

Authors:  J P Kassirer; A J Moskowitz; J Lau; S G Pauker
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

Review 3.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

4.  Monoclonal antibody to Pneumocystis carinii. Comparison with silver stain in bronchial lavage specimens.

Authors:  K S Homer; E L Wiley; A L Smith; L McCollough; D Clark; S D Nightingale; F Vuitch
Journal:  Am J Clin Pathol       Date:  1992-05       Impact factor: 2.493

5.  Forecasting the medical care costs of the HIV epidemic: 1991-1994.

Authors:  F J Hellinger
Journal:  Inquiry       Date:  1991       Impact factor: 1.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.